Genotypic Characterization of UL23 Thymidine Kinase and UL30 DNA Polymerase of Clinical Isolates of Herpes Simplex Virus: Natural Polymorphism and Mutations Associated with Resistance to Antivirals

Overview

Journal Antimicrob Agents Chemother

Publisher American Society for Microbiology

Specialty Pharmacology

Date 2010 Aug 25

PMID 20733037

Citations 35

Authors

Sonia Burrel

Claire Deback

Henri Agut

David Boutolleau

Affiliations

Soon will be listed here.

Abstract

The molecular mechanisms of herpes simplex virus (HSV) resistance to antiviral drugs interfering with viral DNA synthesis reported so far rely on the presence of mutations within UL23 (thymidine kinase [TK]) and UL30 (DNA polymerase) genes. The interpretation of genotypic antiviral resistance assay results requires the clear distinction between resistance mutations and natural interstrain sequence variations. The objectives of this work were to describe extensively the natural polymorphism of UL23 TK and UL30 DNA polymerase among HSV-1 and HSV-2 strains and the amino acid changes potentially associated with HSV resistance to antivirals. The sequence analysis of the full-length UL23 and UL30 genes was performed. Ninety-four drug-sensitive clinical isolates (43 HSV-1 and 51 HSV-2) and 3 laboratory strains (KOS, gHSV-2, and MS2) were studied for natural polymorphism, and 25 clinical isolates exhibiting phenotypic traits of resistance to antivirals were analyzed for drug resistance mutations. Our results showed that TK and DNA polymerase are highly conserved among HSV strains, with a weaker variability for HSV-2 strains. This study provided a precise map of the natural polymorphism of both viral enzymes among HSV-1 and HSV-2 isolates, with the identification of 15 and 51 polymorphisms never previously described for TK and DNA polymerase, respectively, which will facilitate the interpretation of genotypic antiviral-resistant testing. Moreover, the genotypic characterization of 25 drug-resistant HSV isolates revealed 8 new amino acid changes located in TK and potentially accounting for acyclovir (ACV) resistance.

Citing Articles

The immunobiology of corneal HSV-1 infection and herpetic stromal keratitis.

Antony F, Kinha D, Nowinska A, Rouse B, Suryawanshi A Clin Microbiol Rev. 2024; 37(3):e0000624.

PMID: 39078136 PMC: 11391706. DOI: 10.1128/cmr.00006-24.

Combination of ganciclovir and trifluridine prevents drug-resistance emergence in HSV-1.

Schalkwijk H, Shewakramani N, Das K, Andrei G, Snoeck R Antimicrob Agents Chemother. 2024; 68(5):e0011024.

PMID: 38619252 PMC: 11064611. DOI: 10.1128/aac.00110-24.

Whole-Genome Sequencing of Two Canine Herpesvirus 1 (CaHV-1) Isolates and Clinicopathological Outcomes of Infection in French Bulldog Puppies.

Rocchigiani A, Bertoldi L, Coradduzza E, Lostia G, Pintus D, Scivoli R Viruses. 2024; 16(2).

PMID: 38399985 PMC: 10893542. DOI: 10.3390/v16020209.

Diagnostic performance of real-time quantitative PCR in tear samples in various subtypes of herpes simplex keratitis.

Hoarau G, Haigh O, Vauloup-Fellous C, Boucher R, Rouquette A, Faure P J Clin Microbiol. 2023; 61(12):e0088523.

PMID: 38038483 PMC: 10729708. DOI: 10.1128/jcm.00885-23.

Variant Analysis of the Thymidine Kinase and DNA Polymerase Genes of Herpes Simplex Virus in Korea: Frequency of Acyclovir Resistance Mutations.

Hyun J, Lee S, Kim J, Cho E, Kim H, Kim J Viruses. 2023; 15(8).

PMID: 37632051 PMC: 10458183. DOI: 10.3390/v15081709.

References

Dignani M, Mykietiuk A, Michelet M, Intile D, Mammana L, Desmery P . Valacyclovir prophylaxis for the prevention of Herpes simplex virus reactivation in recipients of progenitor cells transplantation. Bone Marrow Transplant. 2002; 29(3):263-7. DOI: 10.1038/sj.bmt.1703354. View

Duffy K, Quail M, Nguyen T, Wittrock R, Bartus J, Halsey W . Assessing the contribution of the herpes simplex virus DNA polymerase to spontaneous mutations. BMC Infect Dis. 2002; 2:7. PMC: 113270. DOI: 10.1186/1471-2334-2-7. View

Darby G, FIELD H, Salisbury S . Altered substrate specificity of herpes simplex virus thymidine kinase confers acyclovir-resistance. Nature. 1981; 289(5793):81-3. DOI: 10.1038/289081a0. View

Frobert E, Ooka T, Cortay J, Lina B, Thouvenot D, Morfin F . Herpes simplex virus thymidine kinase mutations associated with resistance to acyclovir: a site-directed mutagenesis study. Antimicrob Agents Chemother. 2005; 49(3):1055-9. PMC: 549244. DOI: 10.1128/AAC.49.3.1055-1059.2005. View

Frobert E, Cortay J, Ooka T, Najioullah F, Thouvenot D, Lina B . Genotypic detection of acyclovir-resistant HSV-1: characterization of 67 ACV-sensitive and 14 ACV-resistant viruses. Antiviral Res. 2008; 79(1):28-36. DOI: 10.1016/j.antiviral.2008.01.153. View

Morfin F, Bilger K, Boucher A, Thiebaut A, Najioullah F, Bleyzac N . HSV excretion after bone marrow transplantation: a 4-year survey. J Clin Virol. 2004; 30(4):341-5. DOI: 10.1016/j.jcv.2004.03.002. View

Stranska R, Schuurman R, Scholl D, Jollick J, Shaw C, Loef C . ELVIRA HSV, a yield reduction assay for rapid herpes simplex virus susceptibility testing. Antimicrob Agents Chemother. 2004; 48(6):2331-3. PMC: 415590. DOI: 10.1128/AAC.48.6.2331-2333.2004. View

Thi T, Deback C, Malet I, Bonnafous P, Ait-Arkoub Z, Agut H . Rapid determination of antiviral drug susceptibility of herpes simplex virus types 1 and 2 by real-time PCR. Antiviral Res. 2006; 69(3):152-7. DOI: 10.1016/j.antiviral.2005.11.004. View

Buchman T, Simpson T, Nosal C, Roizman B, Nahmias A . The structure of herpes simplex virus DNA and its application to molecular epidemiology. Ann N Y Acad Sci. 1980; 354:279-90. DOI: 10.1111/j.1749-6632.1980.tb27972.x. View

10.

Gilbert C, Bestman-Smith J, Boivin G . Resistance of herpesviruses to antiviral drugs: clinical impacts and molecular mechanisms. Drug Resist Updat. 2002; 5(2):88-114. DOI: 10.1016/s1368-7646(02)00021-3. View

11.

Kost R, Hill E, Tigges M, Straus S . Brief report: recurrent acyclovir-resistant genital herpes in an immunocompetent patient. N Engl J Med. 1993; 329(24):1777-82. DOI: 10.1056/NEJM199312093292405. View

12.

Gaudreau A, Hill E, Balfour Jr H, Erice A, Boivin G . Phenotypic and genotypic characterization of acyclovir-resistant herpes simplex viruses from immunocompromised patients. J Infect Dis. 1998; 178(2):297-303. DOI: 10.1086/515626. View

13.

Stranska R, van Loon A, Polman M, Beersma M, Bredius R, Lankester A . Genotypic and phenotypic characterization of acyclovir-resistant herpes simplex viruses isolated from haematopoietic stem cell transplant recipients. Antivir Ther. 2004; 9(4):565-75. View

14.

McGeoch D, Moss H, McNab D, Frame M . DNA sequence and genetic content of the HindIII l region in the short unique component of the herpes simplex virus type 2 genome: identification of the gene encoding glycoprotein G, and evolutionary comparisons. J Gen Virol. 1987; 68 ( Pt 1):19-38. DOI: 10.1099/0022-1317-68-1-19. View

15.

Bestman-Smith J, Boivin G . Herpes simplex virus isolates with reduced adefovir susceptibility selected in vivo by foscarnet therapy. J Med Virol. 2002; 67(1):88-91. DOI: 10.1002/jmv.2195. View

16.

Chibo D, Mijch A, Doherty R, Birch C . Novel mutations in the thymidine kinase and DNA polymerase genes of acyclovir and foscarnet resistant herpes simplex viruses infecting an immunocompromised patient. J Clin Virol. 2002; 25(2):165-70. DOI: 10.1016/s1386-6532(02)00005-7. View

17.

Larder B, Kemp S, Darby G . Related functional domains in virus DNA polymerases. EMBO J. 1987; 6(1):169-75. PMC: 553373. DOI: 10.1002/j.1460-2075.1987.tb04735.x. View

18.

Gibbs J, Chiou H, Bastow K, Cheng Y, Coen D . Identification of amino acids in herpes simplex virus DNA polymerase involved in substrate and drug recognition. Proc Natl Acad Sci U S A. 1988; 85(18):6672-6. PMC: 282039. DOI: 10.1073/pnas.85.18.6672. View

19.

Danve-Szatanek C, Aymard M, Thouvenot D, Morfin F, Agius G, Bertin I . Surveillance network for herpes simplex virus resistance to antiviral drugs: 3-year follow-up. J Clin Microbiol. 2004; 42(1):242-9. PMC: 321677. DOI: 10.1128/JCM.42.1.242-249.2004. View

20.

Sarisky R, Nguyen T, Duffy K, Wittrock R, Leary J . Difference in incidence of spontaneous mutations between Herpes simplex virus types 1 and 2. Antimicrob Agents Chemother. 2000; 44(6):1524-9. PMC: 89907. DOI: 10.1128/AAC.44.6.1524-1529.2000. View